Ulixertinib in People With Histiocytic Neoplasms

Clinical trial NCT06411821 · RECRUITING

Trial details

NCT number: NCT06411821
Sponsor: Memorial Sloan Kettering Cancer Center
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Histiocytic Neoplasms

Start date: 2024-05-07
Primary completion: 2027-05-01
Enrollment: 38

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.